- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Visceral medicine, 35, 1, S. 1-2
- Event
-
Veröffentlichung
- (where)
-
Bochum
- (who)
-
Ruhr-Universität Bochum
- (when)
-
2019
- Creator
-
Tannapfel, Andrea
Reinacher-Schick, Anke Claudia
- URN
-
urn:nbn:de:hbz:294-93220
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tannapfel, Andrea
- Reinacher-Schick, Anke Claudia
- Ruhr-Universität Bochum
Time of origin
- 2019
Other Objects (12)
ColVI myopathies: where do we stand, where do we go?
Organizational learning: Where do we stand? Where do we want to go?
Organizational learning: Where do we stand? Where do we want to go?
Organizational learning: Where do we stand? Where do we want to go?
NISQ computing: where are we and where do we go?
Nanoparticles in the environment: where do we come from, where do we go to?
Peptide-based immunotherapy in lupus: Where are we now?
EU-China trade relations : Where do we stand, where should we go?
Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Where Are We Now and Where Are We Headed?
3D webservices - where do we stand?
Where do we go from here?
Microbiological surveillance – where do we stand?
ColVI myopathies: where do we stand, where do we go?
Organizational learning: Where do we stand? Where do we want to go?
Organizational learning: Where do we stand? Where do we want to go?
Organizational learning: Where do we stand? Where do we want to go?
NISQ computing: where are we and where do we go?
Nanoparticles in the environment: where do we come from, where do we go to?
Peptide-based immunotherapy in lupus: Where are we now?
EU-China trade relations : Where do we stand, where should we go?
Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Where Are We Now and Where Are We Headed?
3D webservices - where do we stand?
Where do we go from here?
Microbiological surveillance – where do we stand?
ColVI myopathies: where do we stand, where do we go?
Organizational learning: Where do we stand? Where do we want to go?
Organizational learning: Where do we stand? Where do we want to go?
Organizational learning: Where do we stand? Where do we want to go?
NISQ computing: where are we and where do we go?
Nanoparticles in the environment: where do we come from, where do we go to?
Peptide-based immunotherapy in lupus: Where are we now?
EU-China trade relations : Where do we stand, where should we go?
Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Where Are We Now and Where Are We Headed?
3D webservices - where do we stand?
Where do we go from here?